Autoantibodies in viral hepatitis-related hepatocellular carcinoma.
Patients with hepatocellular carcinoma (HCC) develop autoantibodies to nuclear and nucleolar antigens (ANAs) which can be readily detected by immunofluorescence on cell substrates. The frequency of ANAs in HCC is 31% (57/184). The identity of three autoantigens was established as: NOR-90, nucleolus organizer region (doublet) polypeptides involved in RNA polymerase I transcription; fibrillarin, a component of nucleolar U3 RNP involved in pre-ribosomal RNA processing, and nucleophosmin/protein B23, a nucleolar protein involved in ribosome maturation and cell proliferation. Changes in ANAs were observed in some patients during transition from chronic liver disease to HCC and were manifested as seroconversion from ANA-negative to ANA-positive status by an increase in titers and changes in ANA specificities. Serum from a patient during this transition period was used to isolate a cDNA clone encoding a novel nuclear protein with structural motifs characteristic of a family of splicing factors. These observations support the notion that ANA responses in HCC might be driven by intracellular events related to transformation from the stage of chronic injury to the stage of malignancy. Changes in ANA profiles which were observed to precede clinically diagnosed HCC in some patients might be early markers of transformation.
Imai
H
H
W. M. Keck Autoimmune Disease Center, Scripps Research Institute, La Jolla, Calif. 92037.
Kiyosawa
K
K
Chan
E K
EK
Tan
E M
EM
D001323:Autoantibodies / Q000276:immunology*; D001324:Autoantigens / Q000276:immunology; D006528:Carcinoma, Hepatocellular / Q000150:complications / Q000276:immunology*; D006505:Hepatitis / Q000150:complications; D006801:Humans; D009687:Nuclear Proteins / Q000276:immunology
D001323:Autoantibodies; D001324:Autoantigens; D009687:Nuclear Proteins